Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $633.30 million. The enterprise value is $301.89 million.

Market Cap	633.30M
Enterprise Value	301.89M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026, before market open.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

CGEM has 59.08 million shares outstanding. The number of shares has increased by 18.23% in one year.

Current Share Class	59.08M
Shares Outstanding	59.08M
Shares Change (YoY)	+18.23%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	1.02%
Owned by Institutions (%)	86.36%
Float	45.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.40
P/TBV Ratio	1.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.45, with a Debt / Equity ratio of 0.00.

Current Ratio	10.45
Quick Ratio	10.15
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.18% and return on invested capital (ROIC) is -27.87%.

Return on Equity (ROE)	-40.18%
Return on Assets (ROA)	-26.53%
Return on Invested Capital (ROIC)	-27.87%
Return on Capital Employed (ROCE)	-53.49%
Revenue Per Employee	n/a
Profits Per Employee	-$1.95M
Employee Count	111
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CGEM has paid $117,000 in taxes.

Income Tax	117,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.31% in the last 52 weeks. The beta is -0.09, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+5.31%
50-Day Moving Average	10.14
200-Day Moving Average	8.27
Relative Strength Index (RSI)	53.06
Average Volume (20 Days)	851,799

Short Selling Information

The latest short interest is 8.14 million, so 13.77% of the outstanding shares have been sold short.

Short Interest	8.14M
Short Previous Month	6.82M
Short % of Shares Out	13.77%
Short % of Float	18.05%
Short Ratio (days to cover)	6.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-241.44M
Pretax Income	-216.70M
Net Income	-216.81M
EBITDA	-241.13M
EBIT	-241.44M
Earnings Per Share (EPS)	-$3.68

Balance Sheet

The company has $332.60 million in cash and $1.19 million in debt, with a net cash position of $331.41 million or $5.61 per share.

Cash & Cash Equivalents	332.60M
Total Debt	1.19M
Net Cash	331.41M
Net Cash Per Share	$5.61
Equity (Book Value)	451.37M
Book Value Per Share	7.64
Working Capital	309.48M

Cash Flow

In the last 12 months, operating cash flow was -$174.27 million and capital expenditures -$38,000, giving a free cash flow of -$174.31 million.

Operating Cash Flow	-174.27M
Capital Expenditures	-38,000
Free Cash Flow	-174.31M
FCF Per Share	-$2.95

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.23%
Shareholder Yield	-18.23%
Earnings Yield	-34.24%
FCF Yield	-27.52%

Analyst Forecast

The average price target for CGEM is $28.13, which is 162.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.13
Price Target Difference	162.41%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1